RxDoctor Payments Data

Kayla Milnes, PA

Physician Assistant · Morgantown, WVNPI 1013623537

Payments from drug & device makers

$1,587in general payments, 2019–2025

Across 105 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$437
  • Edwards Lifesciences$264
  • Novartis$171
  • Boston Scientific$122
  • Philips North America LLC$78
  • AstraZeneca$77
  • plus $438 from 11 others

What the payments were for

  • Food & beverage$1,587100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,587 in reported general payments places this provider in the 80th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Medicare billing

Part B allowed, 2024
$17,145
Medicare patients
169
Services billed
331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan52$79,120
Repatha SureclickEvolocumab52$59,772
EliquisApixaban48$56,955
BrilintaTicagrelor18$20,746
Rosuvastatin Calcium138$2,086
Metoprolol Succinate109$1,575
Ranolazine ErRanolazine21$1,533
Nebivolol Hcl13$1,452
ClopidogrelClopidogrel Bisulfate111$1,208
Ezetimibe44$1,178
Nitroglycerin PatchNitroglycerin18$932
Atorvastatin Calcium77$779
Prasugrel Hcl12$751
Isosorbide Mononitrate ErIsosorbide Mononitrate53$616
Amlodipine Besylate97$576

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$171$79,12052 claims
PfizerEliquis$64$56,95548 claims
AstraZenecaBrilinta$77$20,74618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Morgantown

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →